BlackRock’s Black Diamond Therapeutics BDTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.36M Buy
1,106,840
+218,580
+25% +$520K ﹤0.01% 4087
2025
Q4
$2.16M Sell
888,260
-139,832
-14% -$495K ﹤0.01% 4095
2025
Q3
$3.9M Sell
1,028,092
-62,771
-6% -$184K ﹤0.01% 3876
2025
Q2
$2.71M Sell
1,090,863
-2,381,893
-69% -$4.59M ﹤0.01% 3981
2025
Q1
$5.38M Sell
3,472,756
-46,389
-1% -$97.3K ﹤0.01% 3622
2024
Q4
$7.53M Buy
3,519,145
+21,379
+0.6% +$61.3K ﹤0.01% 3559
2024
Q3
$15.2M Buy
3,497,766
+280,638
+9% +$1.53M ﹤0.01% 3198
2024
Q2
$15M Buy
3,217,128
+1,836,606
+133% +$9.86M ﹤0.01% 3149
2024
Q1
$7M Buy
1,380,522
+30,475
+2% +$123K ﹤0.01% 3534
2023
Q4
$3.79M Sell
1,350,047
-50,058
-4% -$117K ﹤0.01% 3801
2023
Q3
$4.02M Sell
1,400,105
-105,334
-7% -$388K ﹤0.01% 3738
2023
Q2
$7.6M Buy
1,505,439
+749,052
+99% +$1.53M ﹤0.01% 3543
2023
Q1
$1.43M Sell
756,387
-237,382
-24% -$545K ﹤0.01% 4204
2022
Q4
$1.79M Sell
993,769
-269,748
-21% -$486K ﹤0.01% 4180
2022
Q3
$2.14M Sell
1,263,517
-8,595
-0.7% -$26.5K ﹤0.01% 4166
2022
Q2
$3.13M Sell
1,272,112
-1,057,052
-45% -$2.46M ﹤0.01% 4035
2022
Q1
$6.45M Buy
2,329,164
+80,697
+4% +$295K ﹤0.01% 3817
2021
Q4
$12M Buy
2,248,467
+57,837
+3% +$404K ﹤0.01% 3564
2021
Q3
$18.5M Buy
2,190,630
+36,418
+2% +$360K ﹤0.01% 3328
2021
Q2
$26.3M Buy
2,154,212
+223,627
+12% +$4.42M ﹤0.01% 3132
2021
Q1
$46.8M Buy
1,930,585
+257,447
+15% +$6.94M ﹤0.01% 2661
2020
Q4
$53.6M Buy
1,673,138
+575,818
+52% +$18.9M ﹤0.01% 2424
2020
Q3
$33.2M Buy
1,097,320
+344,952
+46% +$10.5M ﹤0.01% 2539
2020
Q2
$31.7M Buy
752,368
+184,680
+33% +$6.8M ﹤0.01% 2541
2020
Q1
$14.2M Buy
+567,688
New +$17.3M ﹤0.01% 2796

Other funds holding BDTX